联合应用奥拉西坦与疏血通治疗原发性脑出血43例.docVIP

精品论文 参考文献 联合应用奥拉西坦与疏血通治疗原发性脑出血43例 浏阳市人民医院 湖南浏阳 410300 【摘 要】目的 探讨奥拉西坦联合疏血通治疗原发性脑出血的临床疗效。方法 选取我院2014年6月-2016年6月收治的86例原发性脑出血患者为研究对象，将其随机分为观察组和对照组各43例，观察组患者给予奥拉西坦联合疏血通治疗，对照组患者给予胞磷胆碱钠治疗，均治疗3周，评价两组患者的临床疗效。结果 治疗后，两组患者的MMSS评分和NIHSS评分均明显优于治疗前，分别比较差异显著（Plt;0.01），观察组患者的MMSS评分和NIHSS评分均优于对照组，分别比较差异有统计学意义（Plt;0.05）；治疗期间两组患者均未发生不良反应，未出现身体机能指标严重异常现象。治疗前后进行CT或MRI检查未见血肿面积扩大或再次出血病例。结论 奥拉西坦联合疏血通治疗原发性脑出血，能显著改善患者的神经功能和认知功能，且具有较高的安全性，值得临床推广。 【关键词】奥拉西坦；原发性脑出血；临床疗效 [Abstract]objective to explore the olathe joint ShuXieTong treatment the clinical curative effect of primary intracerebral hemorrhage.Methods select our June 2014 - June 2016 86 patients with primary intracerebral hemorrhage were treated as the research object，its each 43 patients were randomly divided into observation group and control group，observation group patients give olathe joint ShuXieTong treatment，control group patients give citicoline sodium treatment，treatment for 3 weeks，to evaluate the clinical efficacy of two groups of patients.Results after treatment，two groups of patients with MMSS score and NIHSS scores were significantly better than the before treatment，respectively，the more significant difference（P lt; 0.01），the observation group of patients with MMSS score and NIHSS scores were better than control group，respectively，compare the difference was statistically significant（P lt; 0.05）；During the treatment of two groups of patients were not adverse reactions，does not appear serious anomaly body function index.Was not seen hematoma CT or MRI before and after the treatment area to expand or hemorrhage cases again.Conclusion olathe joint ShuXieTong treatment of primary cerebral hemorrhage，can significantly improve the patients nerve function and cognitive function，and has high security，worth clinical promotion. [Key words]olathe temple；Primary intracerebral hemorrhage；Clinical curative effect 原发性脑出血是临床常见病、多发病，是我国重要致死疾病之一[1]。临床治疗上主要以尽快终止出血、消肿、有效减轻对脑部损伤为目的，以尽可能减轻神经功能的损伤，促进受损神经功能的恢复。奥拉西坦对促进受损神经功能恢复有积极作用，疏